2,627
Views
4
CrossRef citations to date
0
Altmetric
Perceptions of Science: Public Trust

Science communication and public trust in science

ORCID Icon

References

  • Altenmüller, Marlene S., Stephen Nuding, and Mario Gollwitzer. 2021. “No Harm in Being Selfcorrection: Self-Criticism and Reform Intentions Increase Researchers’ Epistemic Trustworthiness and Credibility in the Eyes of the Public.” Public Understanding of Science 30 (8): 962–976.
  • Baier, Anette. 1986. “Trust and Anti-trust.” Ethics 96: 231–260.
  • Bromme, R., N. G. Mede, E. Thomm, B. Kremer, and R. Ziegler. 2022. “An Anchor in Troubled Times: Trust in Science Before and Within the COVID-19 Pandemic.” PloS one 17 (2): e0262823.
  • Burki, Talha. 2020. “Covid-19 in Latin America.” The Lancet Infectious Diseases 20 (5): 547–548.
  • Chai, P. R., E. G. Ferro, J. M. Kirshenbaum, B. D. Hayes, S. E. Culbreth, E. W. Boyer, and T. B. Erickson. 2020. “Intentional Hydroxychloroquine Overdose Treated with High-Dose Diazepam: An Increasing Concern in the COVID-19 Pandemic.” Journal of Medical Toxicology 16: 314–320.
  • Chen, Z., J. Hu, S. Jiang, S. Han, D. Yan, R. Zhuang, and B. Hu. 2020. “Efficacy of Hydroxychloroquine in Patients with COVID-19: Results of a Randomized Clinical Trial.” MedRxiv. https://www.medrxiv.org/content/10.11012020.03.22.20040758v3.
  • Cheng, K. K., T. H. Lam, and C. C. Leung. 2020. “Wearing Face Masks in the Community During the COVID-19 Pandemic: Altruism and Solidarity.” The Lancet 399 (10336): e39–e40.
  • Cunningham-Burley, Sarah. 2006. “Public Knowledge and Public Trust.” Public Health Genomics 9 (3): 204–210.
  • de Melo-Martín, Inmaculada, and Kristen Intemann. 2012. “Interpreting Evidence: Why Values Can Matter as Much as Science.” Perspectives Biolology and Medicine 55 (1): 59–70.
  • de Melo-Martín, Inmaculada, and Kristen Intemann. 2018. The Fight Against Doubt: How to Bridge the gap Between Scientists and the Public. Oxford: Oxford University Press.
  • Department of Health and Social Care, United Kingdom. 2020. “World’s Largest Trial of Potential Coronavirus Treatments Rolled out Across the UK.” https://www.gov.uk/government/news/worlds-largest-trial-of-potential-coronavirus-treatments-rolled-out-across-the-uk.
  • Druckman, J. N., S. Klar, Y. Krupnikov, M. Levendusky, and J. B. Ryan. 2021. “Affective Polarization, Local Contexts and Public Opinion in America.” Nature Human Behaviour 5 (1): 28–38.
  • Dudley, M. Z., R. Bernier, J. Brewer, and D. A. Salmon. 2021. “Walking the Tightrope: Reevaluating Science Communication in the Era of COVID-19 Vaccines.” Vaccine 39 (39): 5453–5455.
  • Esmaeilzadeh, Pouyan. 2022. “Public Concerns and Burdens Associated with Face Mask-Wearing: Lessons Learned from the COVID-19 Pandemic.” Progress in Disaster Science 13: 100215.
  • Galaitsi, S. E., J. C. Cegan, K. Volk, M. Joyner, B. D. Trump, and I. Linkov. 2021. “The Challenges of Data Usage for the United States’ COVID-19 Response.” International Journal of Information Management 59: 102352.
  • Gautret, Philippe, Jean-Christophe Lagier, Philippe Parola, Van Thuan Hoang, Line Meddeb, Morgane Mailhe, Barbara Doudier, et al. 2020. “Hydroxychloroquine and Azithromycin as a Treatment of COVID-19: Results of an Open-label non-Randomized Clinical Trial.” International Journal of Antimicrobial Agents 56 (1): 105949.
  • Ghebreyesus AT. “WHO Director-General’s Opening Remarks at the Media Briefing on COVID-19 – 18 March 2020.” 2020. https://www.who.int/dg/speeches/detail/who-director-general-s-opening-remarks-at-the-media-briefing-on-covid-19%2D%2D-18-march-2020.
  • Goldenberg, Maya J. 2021. Vaccine Hesitancy: Public Trust, Expertise, and the War on Science. Pittsburgh: University of Pittsburgh Press.
  • Hardin, Russell. 2006. Trust. Cambridge: Polity Press.
  • Hardwig, John. 1991. “The Role of Trust in Knowledge.” Journal of Philosophy 88 (12): 693–708.
  • He, Lu, Changyang He, Tera L Reynolds, Qiushi Bai, Yicong Huang, Chen Li, and Kai Zheng. 2021. “Why Do People Oppose Mask Wearing? A Comprehensive Analysis of US Tweets During the COVID-19 Pandemic.” Journal of the American Medical Informatics Association 28 (7): 1564–1573.
  • Hendriks, Friederike, Dorothe Kienhues, and Rainer Bromme. 2015. "Measuring Laypeople’s Trust in Experts in a Digital Age: The Muenster Epistemic Trustworthiness Inventory (METI)." PloS ONE 10 (10): e0139309.
  • Hendriks, Friederike, Inse Janssen, and Regina Jucks. 2022. “Balance as Credibility? How Presenting One- vs. Two-Sided Messages Affects Ratings of Scientists’ and Politicians’ Trustworthiness.” Health Communication, 1–8. doi:10.1080/10410236.2022.2111638.
  • Intemann, Kristen. 2020. “Understanding the Problem of ‘Hype’: Exaggeration, Values, and Trust in Science.” Canadian Journal of Philosophy 52 (3): 279–294.
  • John, Stephen. 2018. “Epistemic Trust and the Ethics of Science Communication: Against Transparency, Openness, Sincerity and Honesty.” Social Epistemology 32 (2): 75–87.
  • Ledford, Heidi. 2020. “Chloroquine Hype is Derailing the Search for Coronavirus Treatments.” Nature 580 (7805): 573.
  • Leonhardt, David. 2021. “Vaccine Alarmism.” New York Times, February 19 https://www.nytimes.com/2021/02/19/briefing/ted-cruz-texas-water-iran-nuclear.html.
  • Lewis, Dyani. 2022. “Why the WHO Took Two Years to Say COVID is Airborne.” Nature 604 (7904): 26–31.
  • Mason, Chris, and Elisa Manzotti. 2009. “Induced Pluripotent Stem Cells: An Emerging Technology Platform and the Gartner Hype Cycle.” Regenerative Medicine 4: 329–331.
  • Master, Zubin, and Vural Özdemir. 2008. "Selling Translational Research: Is Science a Value-Neutral Autonomous Enterprise?." The American Journal of Bioethics 8 (3): 52–54.
  • Master, Zubin, and David B Resnik. 2013. “Hype and Public Trust in Science.” Science and Engineering Ethics 19 (2): 321–335.
  • Mayer, Roger C., James H. Davis, and F. David Schoorman. 1995. “An Integrative Model of Organizational Trust.” Academy of Management Review 20 (3): 709–734.
  • McKaughan, Daniel J., and Kevin C Elliott. 2013. “Backtracking and the Ethics of Framing: Lessons from Voles and Vasopressin.” Accountability in Research 20 (3): 206–226.
  • McKaughan, Daniel J., and Kevin Elliott. 2018. “Just the Facts or Expert Opinion? The Backtracking Approach to Socially Responsible Science Communication.” In Ethics and Practice in Science Communication, edited by S. Priest, J. Goodwin, and M. F. Dahlstrom, 197–213. Chicago, IL: University of Chicago Press.
  • Medvecky, Fabien, and Joan Leach. 2019. An Ethics of Science Communication. Cham: Springer.
  • Mehta, Bella, Jane Salmon, and Said Ibrahim. 2020. “Potential Shortages of Hydroxychloroquine for Patients with Lupus During the Coronavirus Disease 2019 Pandemic.” JAMA Health Forum 1 (4): e200438.
  • Nagler, R. H., R. I. Vogel, S. E. Gollust, A. J. Rothman, E. F. Fowler, and M. C. Yzer. 2020. “Public Perceptions of Conflicting Information Surrounding COVID-19: Results from a Nationally Representative Survey of US Adults.” PloS one 15 (10): e0240776.
  • Nisbet, Matthew C., and Dietram A Scheufele. 2009. “What’s Next for Science Communication? Promising Directions and Lingering Distractions.” American Journal of Botany 96 (10): 1767–1778.
  • Noar, Seth M., and Lucinda Austin. 2020. “(Mis)Communicating About COVID-19: Insights from Health and Crisis Communication.” Health Communication 35 (14): 1735–1739.
  • Odenbaugh, Jay. 2008. “Ecology and the Inescapability of Values.” Science and Engineering Ethics 14 (4): 593–596.
  • Peeples, Lynne, et al. 2020. “What the Data Say about Wearing Face Masks.” Nature 586 (7828): 186–189.
  • Priest, Susanna. 2013. “Can Strategic and Democratic Goals Coexist in Communicating Science? Nanotechnology as a Case Study in the Ethics of Science Communication and the Need for ‘Critical’ Science Literacy.” In Ethical Issues in Science Communicatin: A Theory-based Approach, edited by J. Goodwin, M. F. Dahlstrom, and S. Priest, 229–243. Charleston, SC: CreateSpace.
  • Quinn, Sandra C., Amelia M. Jamison, and Vicki Freimuth. 2020. "Communicating Effectively about Emergency Use Authorization and Vaccines in the COVID-19 Pandemic." American Journal of Public Health 111 (3): 355–358.
  • Rowan, Katherine E. 1991. "When Simple Language Fails: Presenting Difficult Science to the Public." Journal of Technical Writing and Communication 21 (4): 369–382.
  • Ruiu, Maria L. 2020. “Mismanagement of Covid-19: Lessons Learned from Italy.” Journal of Risk Research 23 (7–8): 1007–1020.
  • Scheman, Naomi. 2011. Shifting Ground: Knowledge and Reality, Transgression and Trustworthiness. Oxford: Oxford University Press.
  • Schrage, Michael. 2004. “Great Expectations.” MIT Technology Review 107 (8): 2.
  • Singh, Jerome A., and Rafaella Ravinetto. 2020. “COVID-19 Therapeutics: How to Show Confusion and Break Public Trust During International Public Health Emergencies.” Journal of Pharmaceutical Policy and Practice 13 (1): 1–7.
  • Taylor, Marisa, and Aram Roston. 2020. “Pressed by Trump, U.S. Pushed Unproven Coronavirus Treatment Guidance.” https://news.trust.org/item/20200404170001-la0q3/.
  • Warren, George W., and Ragnar Lofstedt. 2021. “Risk Communication and COVID-19 in Europe: Lessons for Future Public Health Crises.” Journal of Risk Research 25 (10): 1–15.
  • Warraich, Haider J. 2020. “The Risks of Trump’s Hydroxychloroquine Hype.” New York Times, May 19. https://www.nytimes.com/2020/05/19/opinion/trump-hydroxychloroquine-coronavirus.html.
  • Weingart, Peter, Anita Engels, and Petra Pansegrau. 2000. “Risks of Communication: Discourses on Climate Change in Science, Politics, and the Mass Media.” Public Understanding of Science 9 (3): 261–284.
  • Weingart, Peter, and Lars Guenther. 2016. “Science Communication and the Issue of Trust.” Journal of Science Communication 15 (5): 1–11.
  • Wilholt, Torsten. 2013. “Epistemic Trust in Science.” British Journal for the Philosophy of Science 64 (2): 233–253.